Press Release | AUG 20: NIH Funding and Moving to Trials
Oceanit Laboratories’ ASSURE-19 rapid point-of-need COVID-19 test has been selected for continued support by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative, to fill the nation’s critical need for rapid, simple, and affordable COVID-19 testing.
Honolulu Civil Beat – Widespread, Frequent COVID-19 Testing ‘Can Wipe This Off The Planet’
Senior business writer, Stewart Yerton mentioned Oceanit’s ASSURE-19 tests in his Civil Beat article as a possible solution to the expensive, delayed, and low-availability PCR testing in the State of Hawaii. Click to read more.
KITV Island News – Patrick K. Sullivan Discusses ASSURE-19
On Monday, August 3rd, Dr. Sullivan joined KITV 4’s Evening Island News program for a live interview about ASSURE-19’s progress. Hosts Mika Miyashima and Brenton Awa on heard about our progress, how the test works, scale up plans, and how ASSURE-19 has the potential to reopen Hawaii. Click to watch.
Honolulu Star Advertiser: Hawaii Coronavirus Saliva Test Could Help Turn Pandemic’s Tide
CEO Dr. Patrick Sullivan spoke to The Star Advertiser’s Mindy Pennybacker about how the ASSURE-19 rapid “spit test” can help to protect lives and responsibly help to restore the economy and the unique ‘capture and detector molecule’ approach to COVID-19 respiratory disease detection. Click to read more.
Hawaii News Now – COVID-19 Spit Test
Oceanit welcomed Hawaii News Now to our Downtown Honolulu labs to introduce the ASSURE-19 rapid diagnostic test. Pat Sullivan, CEO of Oceanit joined HNN host, Mahealani Richardson to discuss our recent progress, participation in NIH’s RADx program. Click to read more.
Hawaii Public Radio: Bytemarks Cafe
Dr. Patrick Sullivan joined Hawaii Public Radio Host, Burt Lum on the Bytemarks Cafe program to discuss Oceanit’s development of ASSURE-19. With the opening up of Hawaii’s economy dependent on rapid, reliable, and available COVID-19 testing, they discussed how can Hawaii keep up and overcome test supply shortages. Click to read more.